About this document

Cipla Ascend Season 2: Growth Strategies by Dhanush Basavanna is a document available to read on EtoBox.

The Indian pharmaceutical industry is valued at approximately US$50 billion in 2023, with Cipla being the third largest company in the market, focusing on generic drugs and expanding into consumer OTC and digital health segments. The case study aims to identify a new business segment for Cipla

Author

Dhanush Basavanna

Language

EN